ImmunoGen, Inc. IMGN
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 8.72B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 86.75
- Beta
- 1.17
- Short ratio
- 3.78
- Inst. own
- 86.52%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 6, 2024
- 50-d avg
- 29.71
- 200-d avg
- 19.72
- 1y target
- 25.50
MAX chart
Chart tools
Chart is warming up
The all-time price history for IMGN has not been loaded yet. Try again in a moment.
Altman Z-Score
18.14 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -5.6×
P/S 11.6×
P/B 8.1×
P/FCF -5.4×
EV/EBITDA -4.6×
EV/Sales 9.2×
FCF Yield -18.4%
Gross Margin 99.8%
Operating Margin -203.1%
Net Margin -204.9%
ROE -143.1%
ROIC -95.6%
ROA -63.9%
Revenue 55.7%
Operating Income -76.6%
EPS (diluted) 18.7%
Free Cash Flow 0.0%
Current Ratio 2.3×
Quick Ratio 2.5×
Debt / Equity 0.1×
Net Debt / EBITDA 1.2×
Interest Coverage -53.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31